Titre : | High-risk behaviors and hospitalizations among gamma hydroxybutyrate (GHB) users |
Titre traduit : | (Comportements à risque élevé et hospitalisations chez les usagers de gamma-hydroxybutyrate (GHB).) |
Auteurs : | S. Y. KIM ; I. B. ANDERSON ; J. E. DYER ; J. C. BARKER ; P. D. BLANC |
Type de document : | Périodique |
Année de publication : | 2007 |
Format : | 429-438 |
Note générale : |
American Journal of Drug and Alcohol Abuse, 2007, 33, (3), 429-438
|
Langues: | Anglais |
Discipline : | EPI (Epidémiologie / Epidemiology) |
Mots-clés : |
Thésaurus mots-clés GHB ; HOSPITALISATION ; CONDUITE A RISQUE ; POLYCONSOMMATION ; KETAMINE ; ENQUETE ; MORBIDITEThésaurus géographique ETATS-UNIS |
Résumé : | INTRODUCTION. Little is known about behaviors linked to gamma hydroxybutyrate (GHB) morbidity. METHODS. We surveyed 131 GHB users, using logistic regression to test the associations between the high risk behaviors and hospital treatment for GHB (26 [20%] of subjects). RESULTS. Increased risk of GHB hospital treatment was associated with: co-ingestion of ethanol (OR 5.2; 95% CI 1.7-16), driving under the influence of GHB (OR 3.2; 95%, CI 1.3-7.8),use of GHB to treat withdrawal symptoms (OR 2.9; 95% CI 1.1-7.9), and co-ingestion of ketamine (OR 2.7; 95% CI 1.1-6.7). CONCLUSION. Targeted prevention activities could focus on selected high-risk behaviors. (Author' s abstract) |
Domaine : | Drogues illicites / Illicit drugs |
Refs biblio. : | 21 |
Affiliation : |
California Poison Control System, Department of Clinical Pharmacy, University of California, San Francisco, CA 94143-1369. Etats-Unis. United States. |
Numéro Toxibase : | 1302189 |
Centre Emetteur : | 13 OFDT |
Cote : | A03336 |
Exemplaires
Disponibilité |
---|
aucun exemplaire |
Accueil